Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 13, 2020

SELL
$27.75 - $43.44 $1.32 Million - $2.06 Million
-47,443 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$21.5 - $54.2 $1.02 Million - $2.57 Million
47,443 New
47,443 $1.54 Million

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $329M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Foresite Capital Management Ii, LLC Portfolio

Follow Foresite Capital Management Ii, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foresite Capital Management Ii, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foresite Capital Management Ii, LLC with notifications on news.